Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $1.341B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 1,500,000 | $160M | 11.9% | $120.26 | -8.6% | SHS USD | G50871105 |
| CYTK | Cytokinetics Inc | 2,075,000 | $112M | 8.4% | $76.39 | -21.0% | COM NEW | 23282W605 |
| ASND | Ascendis Pharma A/S | 750,000 | $102M | 7.6% | $129.08 | — | SPONSORED ADR | 04351P101 |
| RARE | Ultragenyx Pharmaceutical Inc | 1,800,000 | $73.98M | 5.5% | $42.97 | -0.6% | COM | 90400D108 |
| GMED | Globus Medical Inc | 900,000 | $61.64M | 4.6% | $49.74 | +20.1% | CL A | 379577208 |
| INSM | Insmed Inc | 750,000 | $50.25M | 3.7% | $25.93 | +49.6% | COM PAR $.01 | 457669307 |
| ONC | BeiGene Ltd | 350,000 | $49.93M | 3.7% | $155.41 | — | SPONSORED ADR | 07725L102 |
| SLNO | Soleno Therapeutics Inc | 1,200,000 | $48.96M | 3.7% | $28.45 | +48.9% | COM | 834203309 |
| EXAS | Exact Sciences Corp | 925,000 | $39.08M | 2.9% | $55.91 | -1.6% | COM | 30063P105 |
| ACLX | Arcellx Inc | 675,000 | $37.25M | 2.8% | $54.07 | +0.5% | COMMON STOCK | 03940C100 |
| IMTX | Immatics NV | 2,750,000 | $31.95M | 2.4% | $10.37 | +8.7% | SHS | N44445109 |
| JANX | Janux Therapeutics Inc | 725,000 | $30.37M | 2.3% | $46.95 | 0.0% | COM | 47103J105 |
| — | Astria Therapeutics Inc | 3,250,000 | $29.57M | 2.2% | $10.78 | — | COM | 04635X102 |
| KALV | KalVista Pharmaceuticals Inc | 2,300,000 | $27.09M | 2.0% | $12.14 | -3.9% | COM | 483497103 |
| SVRA | Savara Inc | 6,490,000 | $26.15M | 2.0% | $4.45 | 0.0% | COM | 805111101 |
| — | iTeos Therapeutics Inc | 1,750,000 | $25.97M | 1.9% | $14.84 | — | COM | 46565G104 |
| — | Applied Therapeutics Inc | 5,430,000 | $25.36M | 1.9% | $4.03 | — | COM | 03828A101 |
| AXSM | Axsome Therapeutics Inc | 300,000 | $24.15M | 1.8% | $74.04 | 0.0% | COM | 05464T104 |
| GPCR | Structure Therapeutics Inc | 560,000 | $21.99M | 1.6% | $39.27 | — | SPONSORED ADS | 86366E106 |
| LQDA | Liquidia Corp | 1,830,000 | $21.96M | 1.6% | $10.47 | +26.8% | COM NEW | 53635D202 |
| ALXO | ALX Oncology Holdings Inc | 3,600,000 | $21.71M | 1.6% | $11.47 | +7.2% | COM | 00166B105 |
| QURE | uniQure NV | 4,750,000 | $21.28M | 1.6% | $6.46 | -24.6% | SHS | N90064101 |
| BMY | Bristol-Myers Squibb Co | 500,000 | $20.77M | 1.5% | $41.01 | 0.0% | COM | 110122108 |
| XENE | Xenon Pharmaceuticals Inc | 525,000 | $20.47M | 1.5% | $41.01 | -2.5% | COM | 98420N105 |
| PRAX | Praxis Precision Medicines Inc | 440,000 | $18.2M | 1.4% | $46.11 | +2.5% | COM NEW | 74006W207 |
| DAWN | Day One Biopharmaceuticals Inc | 1,250,000 | $17.23M | 1.3% | $14.63 | 0.0% | COM | 23954D109 |
| — | Inari Medical Inc | 350,000 | $16.85M | 1.3% | $47.98 | — | COM | 45332Y109 |
| DNTH | Dianthus Therapeutics Inc | 600,000 | $15.53M | 1.2% | $19.89 | +20.9% | COM | 252828108 |
| SLDB | Solid Biosciences Inc | 2,665,000 | $15.11M | 1.1% | $9.03 | -0.9% | COM NEW | 83422E204 |
| LXEO | Lexeo Therapeutics Inc | 840,000 | $13.47M | 1.0% | $14.76 | -1.6% | COM | 52886X107 |
| APLS | Apellis Pharmaceuticals Inc | 335,000 | $12.85M | 1.0% | $57.68 | -21.5% | COM | 03753U106 |
| IMNM | Immunome Inc | 1,000,000 | $12.1M | 0.9% | $15.64 | 0.0% | COM | 45257U108 |
| DNLI | Denali Therapeutics Inc | 500,000 | $11.61M | 0.9% | $19.20 | 0.0% | COM | 24823R105 |
| NRIX | Nurix Therapeutics Inc | 500,000 | $10.44M | 0.8% | $15.57 | 0.0% | COM | 67080M103 |
| BDTX | Black Diamond Therapeutics Inc | 2,100,000 | $9.786M | 0.7% | $5.37 | 0.0% | COM | 09203E105 |
| BNTX | BioNTech SE | 100,000 | $8.036M | 0.6% | $80.36 | — | SPONSORED ADS | 09075V102 |
| INSP | Inspire Medical Systems Inc | 60,000 | $8.03M | 0.6% | $189.24 | 0.0% | COM | 457730109 |
| PCRX | Pacira BioSciences Inc | 280,000 | $8.011M | 0.6% | $28.69 | -0.8% | COM | 695127100 |
| DYN | Dyne Therapeutics Inc | 225,000 | $7.94M | 0.6% | $29.06 | 0.0% | COM | 26818M108 |
| FULC | Fulcrum Therapeutics Inc | 1,160,000 | $7.192M | 0.5% | $5.69 | +33.0% | COM | 359616109 |
| ANRO | Alto Neuroscience Inc | 620,000 | $6.628M | 0.5% | $14.08 | -7.6% | COM SHS | 02157Q109 |
| FATE | Fate Therapeutics Inc | 2,000,000 | $6.56M | 0.5% | $3.57 | +22.6% | COM | 31189P102 |
| ALLO | Allogene Therapeutics Inc | 2,200,000 | $5.126M | 0.4% | $3.70 | -20.3% | COM | 019770106 |
| — | Passage Bio Inc | 6,052,000 | $4.806M | 0.4% | $1.21 | — | COM | 702712100 |
| VYGR | Voyager Therapeutics Inc | 600,000 | $4.746M | 0.4% | $9.31 | — | COM | 92915B106 |
| GLPG | Galapagos NV | 180,000 | $4.46M | 0.3% | $36.24 | — | SPON ADR | 36315X101 |
| ZYME | Zymeworks Inc | 440,000 | $3.744M | 0.3% | $8.90 | 0.0% | COM | 98985Y108 |
| RLMD | Relmada Therapeutics Inc | 1,200,000 | $3.6M | 0.3% | $4.64 | -22.0% | COM | 75955J402 |
| MGNX | MacroGenics Inc | 800,000 | $3.4M | 0.3% | $14.61 | -33.3% | COM | 556099109 |
| GLUE | Monte Rosa Therapeutics Inc | 890,000 | $3.329M | 0.2% | $5.10 | 0.0% | COM | 61225M102 |
| VTYX | Ventyx Biosciences Inc | 1,315,000 | $3.038M | 0.2% | $4.15 | 0.0% | COM | 92332V107 |
| PTCT | PTC Therapeutics Inc | 90,000 | $2.752M | 0.2% | $32.39 | 0.0% | COM | 69366J200 |
| — | Verve Therapeutics Inc | 500,000 | $2.44M | 0.2% | $4.88 | — | COM | 92539P101 |
| IOVA | Iovance Biotherapeutics Inc | 300,000 | $2.406M | 0.2% | $10.72 | 0.0% | COM | 462260100 |
| PRME | Prime Medicine Inc | 450,000 | $2.313M | 0.2% | $7.28 | -16.8% | COM | 74168J101 |
| — | Chimerix Inc | 1,400,000 | $1.226M | 0.1% | $0.96 | — | COM | 16934W106 |
| — | Achilles Therapeutics PLC | 1,500,000 | $1.222M | 0.1% | $1.22 | — | SPONSORED ADS | 00449L102 |
| ATRA | Atara Biotherapeutics Inc | 112,000 | $952K | 0.1% | $15.04 | 0.0% | COM NEW | 046513206 |
| — | Reneo Pharmaceuticals Inc | 545,000 | $823K | 0.1% | $1.56 | — | COM | 75974E103 |
| NAMS | Newamsterdam Pharma Co NV | 25,000 | $480K | 0.0% | $20.06 | 0.0% | ORDINARY SHARES | N62509109 |